Los Angeles, CA, Sept. 14, 2017 -- Natural dietary supplement, Myrtol® 300, was selected as a Specialty Supplement finalist for the SupplySide West CPG Editor’s Choice Awards.
|
|||||
Myrtol® 300 is a dietary supplement that uses a proprietary blend of essential oils to help soothe coughs and support a healthy respiratory system. Other finalists in the Specialty Supplement category include Essential Source, Radical Blends Inc., Twinlab Consolidation Corporation, and Vermont Village Sipping.
The SupplySide editoral team chose five consumer packaged goods (CPG) products in each of the 27 award categories for demonstrated achievements in innovation and market impact. Each product submitted was required to be a new product launched between July 2016 and Summer 2017.
“We have seen many people have a positive experience using Myrtol 300 and we’re very excited to now see a top-tier industry publication recognize the benefits of the product,” said Thomas Höppner, Executive Director, Marketing and Sales at Pohl-Boskamp, creators of Myrtol® 300. “We know the product is very effective and we’re excited to see this finalist status help boost awareness of the benefits of Myrtol 300.”
A recent survey conducted on behalf of Myrtol 300 in January 2017 found that on average, Americans have cold and/or flu symptoms at least five times in a typical year. The survey revealed Americans’ preferences for dietary supplements that help soothe coughs and support their respiratory system without making them feel drowsy.
Myrtol® 300 was created by Pohl-Boskamp, a German-based pharmaceutical business, which has sold approximately 250 million capsules worldwide. The product was originally launched and sold as Gelomyrtol in the European market, and has been used for over 40 years by millions of people in 23 countries around the world.
Award winners will be announced at SupplySide West 2017 during the SupplySide CPG Editor’s Choice Awards Presentations, set for September 27 and 28 at the Mandalay Bay Resort in Las Vegas, Nevada.
To learn more about Myrtol® 300, visit www.TryMyrtol300.com.
About Myrtol® 300
Myrtol® 300 helps soothe coughs due to throat irritation while also helping to support a healthy respiratory system. Recognized as the “German pill” with a funny name, Myrtol® 300 was initially launched in the European market and has been used for more than 40 years by millions of people in 23 different countries. The dietary supplement provides lung and sinus support and helps to clear and maintain a healthy respiratory tract. Now available in the U.S., Myrtol® 300 can be purchased without a prescription.
About Pohl-Boskamp
Pohl-Boskamp is a privately-owned business active in the international pharmaceutical market for 175 years with commercialized products in more than 45 countries, and which has now emerged into the U.S. nutraceutical industry. Through close collaboration with its partners abroad, Pohl-Boskamp focuses on developing and marketing products that positively impact patients' quality of life. It operates in numerous healthcare sectors including pneumology, urology, parasitology, cardiovascular diseases and dermatology. Learn more at Pohl-Boskamp.com.
MEDIA CONTACT: Brittany Galvan (310) 405-0346 [email protected]


American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Anta Sports Expands Global Footprint With Strategic Puma Stake
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 



